Oritavancin is approved for the treatment of adult patients with acute bacterial skin and skin structure infections (SSSIs) caused by or suspected to be caused by susceptible isolates of designated gram-positive microorganisms.
Molecular Weight:
1989.09
Purity:
>99.0%
CAS Number:
[192564-14-0]
Formula:
C86H97Cl3N10O26.2(H3PO4)
Target:
Antibiotic
* VAT and and shipping costs not included. Errors and price changes excepted